Prostate Cancer Trial, Recruiting (NCT06773806)

Prostate Cancer Trial, Recruiting NCT06773806 Sponsor: Institut National de la Santé Et de la Recherche Médicale, France Condition: Prostate Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06773806 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Prostate Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people newly diagnosed with prostate cancer (main study group):

Men newly diagnosed with prostate cancer in Martinique, identified through multi-specialist medical meetings, across all public and private healthcare services over a three-year period
Men aged under 75 years old
Men who have lived in Martinique for at least 6 months
Men whose prostate cancer has been confirmed through a tissue sample (biopsy), with inclusion possible as soon as the urologist receives the result
Men enrolled in a social security or equivalent healthcare coverage scheme
Men who have signed a free and informed consent form

For men with a negative prostate biopsy (Control Group 1):

Men who had a prostate biopsy that came back negative, following an elevated PSA blood test result (above 2.5 ng/ml), identified through urologists or pathologists across Martinique over a three-year period
Men aged under 75 years old
Men who have lived in Martinique for at least 6 months
Men whose age is closely matched (within 5 years) to those in the main study group
Men enrolled in a social security or equivalent healthcare coverage scheme
Men who have signed a free and informed consent form

For men with a low PSA result (Control Group 2):

Men with a PSA blood test result of 2.5 ng/ml or below, taken within the past 3 months, identified through a survey organisation over a three-year period
Men aged under 75 years old
Men who have lived in Martinique for at least 6 months
Men whose age is closely matched (within 5 years) to those in the main study group
Men whose occupation category is matched to men of a similar age in Martinique, based on national statistics data

Who may not be able to join:

Men who are under a legal protection arrangement, such as legal safeguarding, curatorship, or guardianship
Men who are unable to give consent because they do not speak French or Creole

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +33 1 45 59 51 53

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06773806

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France

Phase: Not Applicable

Status: Recruiting

Condition: Prostate Cancer

Trial contact: +33 1 45 59 51 53

More information: https://clinicaltrials.gov/study/NCT06773806

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

For people newly diagnosed with prostate cancer (main study group):

Men newly diagnosed with prostate cancer in Martinique, identified through multi-specialist medical meetings, across all public and private healthcare services over a three-year period
Men aged under 75 years old
Men who have lived in Martinique for at least 6 months
Men whose prostate cancer has been confirmed through a tissue sample (biopsy), with inclusion possible as soon as the urologist receives the result
Men enrolled in a social security or equivalent healthcare coverage scheme
Men who have signed a free and informed consent form

For men with a negative prostate biopsy (Control Group 1):

Men who had a prostate biopsy that came back negative, following an elevated PSA blood test result (above 2.5 ng/ml), identified through urologists or pathologists across Martinique over a three-year period
Men aged under 75 years old
Men who have lived in Martinique for at least 6 months
Men whose age is closely matched (within 5 years) to those in the main study group
Men enrolled in a social security or equivalent healthcare coverage scheme
Men who have signed a free and informed consent form

For men with a low PSA result (Control Group 2):

Men with a PSA blood test result of 2.5 ng/ml or below, taken within the past 3 months, identified through a survey organisation over a three-year period
Men aged under 75 years old
Men who have lived in Martinique for at least 6 months
Men whose age is closely matched (within 5 years) to those in the main study group
Men whose occupation category is matched to men of a similar age in Martinique, based on national statistics data

Who may not be able to join:

Men who are under a legal protection arrangement, such as legal safeguarding, curatorship, or guardianship
Men who are unable to give consent because they do not speak French or Creole

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Institut National de la Santé Et de la Recherche Médicale, France

Registry

ClinicalTrials.gov

Start date

15 April 2026

Est. completion

1 April 2030

Where this trial is recruiting

Martinique

Primary endpoints

Primary Outcome Measure : Measure of association between chlordecone exposure and the risk of prostate cancer.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov